Qube Research & Technologies (QRT)’s Amgen AMGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.2M	Sell	74,400 -55,600	-43%	-$19.8M	0.03%	726
2025 Q4	$42.6M	Sell	130,000 -700	-0.5%	-$222K	0.04%	571
2025 Q3	$36.9M	Buy	130,700 +79,500	+155%	+$23.1M	0.04%	609
2025 Q2	$14.3M	Sell	51,200 -9,500	-16%	-$2.69M	0.01%	1079
2025 Q1	$18.9M	Sell	60,700 -58,700	-49%	-$17.3M	0.02%	774
2024 Q4	$31.1M	Buy	119,400 +36,200	+44%	+$10.7M	0.04%	535
2024 Q3	$26.8M	Buy	83,200 +62,200	+296%	+$20.3M	0.04%	547
2024 Q2	$6.56M	Sell	21,000 -7,400	-26%	-$2.17M	0.01%	1132
2024 Q1	$8.07M	Sell	28,400 -1,300	-4%	-$380K	0.01%	962
2023 Q4	$8.55M	Buy	29,700 +27,100	+1,042%	+$7.38M	0.02%	796
2023 Q3	$699K	Buy	+2,600	New	+$649K	﹤0.01%	1887

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AMGN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Amgen (AMGN) stake by 1,763% in Q1 2026, buying an estimated $49.8M and bringing the position to 147,488 shares worth $51.9M. The position accounts for 0.06% of the portfolio, ranked #417.

Qube Research & Technologies (QRT) first reported a position in AMGN in Q1 2018 and has held it in 27 quarters since. The position peaked at $333M in Q4 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Qube Research & Technologies (QRT) held 147,488 shares of Amgen worth $51.9M as of Q1 2026.
Qube Research & Technologies (QRT) bought 139,570 Amgen shares in Q1 2026, an estimated $49.8M.
Amgen made up 0.06% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #417 holding.
Qube Research & Technologies (QRT) first reported a position in Amgen in Q1 2018 and has held it in 27 quarters since.
Qube Research & Technologies (QRT)'s Amgen position peaked at $333M in Q4 2024.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.